Chemical Abstracts Service (CAS), the world's authority for chemical information, has announced a three-year agreement for SciFinder, the choice for chemistry research, with Kalexsyn, a Contract Research Organization (CRO) uniquely positioned to address the needs of the pharmaceutical and biotechnology communities. Through this partnership, Kalexsyn will provide unlimited searching in SciFinder for every chemist on its staff.
Kalexsyn joins a host of other CROs that have chosen SciFinder to advance research projects. In addition to top ranking CROs globally, 47 of the top 50 pharmaceutical and biotechnology companies, and 46 of the top 50 chemical organisations around the world, rely on SciFinder to save valuable time and money by learning from previously disclosed research that is collected, organised and made discoverable by CAS.
Leaders at CROs recognise that allowing their researchers to have access to the same product their client organisations rely on giving them an advantage in the marketplace. A multi-year, unlimited agreement allows researchers at Kalexsyn to explore discovery opportunities while maintaining a predictable budget.
